These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7658768)

  • 21. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients.
    Jockers-Scherübl MC; Matthies U; Danker-Hopfe H; Lang UE; Mahlberg R; Hellweg R
    J Psychopharmacol; 2003 Dec; 17(4):439-45. PubMed ID: 14870957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cannabis use status on cognitive function, in males with schizophrenia.
    Rabin RA; Zakzanis KK; Daskalakis ZJ; George TP
    Psychiatry Res; 2013 Apr; 206(2-3):158-65. PubMed ID: 23246245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis use and schizophrenia.
    Krebs MO; Goldberger C; Dervaux A
    Am J Psychiatry; 2005 Feb; 162(2):401-2; author reply 402. PubMed ID: 15677615
    [No Abstract]   [Full Text] [Related]  

  • 24. Cannabis and the brain.
    Castle DJ; Ames FR
    Aust N Z J Psychiatry; 1996 Apr; 30(2):179-83. PubMed ID: 8811260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cannabis use on the clinical condition of schizophrenics.
    Negrete JC; Knapp WP
    NIDA Res Monogr; 1986; 67():321-7. PubMed ID: 3092086
    [No Abstract]   [Full Text] [Related]  

  • 26. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions.
    Crean RD; Crane NA; Mason BJ
    J Addict Med; 2011 Mar; 5(1):1-8. PubMed ID: 21321675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts.
    Andréasson S; Allebeck P; Engström A; Rydberg U
    Lancet; 1987 Dec; 2(8574):1483-6. PubMed ID: 2892048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cannabis must not be considered as a mild drug].
    Nau JY
    Rev Med Suisse; 2014 Apr; 10(424):770-1. PubMed ID: 24772812
    [No Abstract]   [Full Text] [Related]  

  • 29. Increasing Proportion of Cannabinoid-Associated Psychotic Disorders: Results of a Single-Center Analysis of Treatment Data From 2011 to 2019.
    Gahr M; Ziller J; Keller F; Schönfeldt-Lecuona C
    J Clin Psychopharmacol; 2020; 40(6):642-645. PubMed ID: 33009227
    [No Abstract]   [Full Text] [Related]  

  • 30. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey.
    Negrete JC; Knapp WP; Douglas DE; Smith WB
    Psychol Med; 1986 Aug; 16(3):515-20. PubMed ID: 3489951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Legalization of cannabis?].
    Nordentoft M
    Ugeskr Laeger; 2013 Mar; 175(11):756. PubMed ID: 23610773
    [No Abstract]   [Full Text] [Related]  

  • 32. Cannabis and brain morphology in recent-onset schizophrenia.
    Cahn W; Hulshoff Pol HE; Caspers E; van Haren NE; Schnack HG; Kahn RS
    Schizophr Res; 2004 Apr; 67(2-3):305-7. PubMed ID: 14984893
    [No Abstract]   [Full Text] [Related]  

  • 33. What every adolescent needs to know: cannabis can cause psychosis.
    Shapiro GK; Buckley-Hunter L
    J Psychosom Res; 2010 Dec; 69(6):533-9. PubMed ID: 21109040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of cannabis among adolescents and young adults in Norway].
    Pedersen W
    Tidsskr Nor Laegeforen; 2008 Aug; 128(16):1825-8. PubMed ID: 18787592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motivational changes of cannabis use prior to and during the course of schizophrenia.
    Schnell T; Gliese R; Schröter R; Kasten E; Gouzoulis-Mayfrank E
    Am J Addict; 2017 Mar; 26(2):122-128. PubMed ID: 28004866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis: a note from Bengal.
    Chowdhury AN
    Addiction; 1996 Jun; 91(6):766-7; discussion 770-3. PubMed ID: 8696238
    [No Abstract]   [Full Text] [Related]  

  • 38. Comments on Hall et al.'s Australian National Drug Strategy Monograph no. 25 "The health and psychological consequences of cannabis use".
    Addiction; 1996 Jun; 91(6):759-62. PubMed ID: 8696235
    [No Abstract]   [Full Text] [Related]  

  • 39. Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals.
    Rolland B; Geoffroy PA; Jardri R; Cottencin O
    Clin Neuropharmacol; 2013; 36(3):98-9. PubMed ID: 23673914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does using marijuana increase the risk for developing schizophrenia?
    Evins AE; Green AI; Kane JM; Murray RM
    J Clin Psychiatry; 2013 Apr; 74(4):e08. PubMed ID: 23656852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.